AMCR vs SLNO · P/E 18, rev $23.51B vs P/E 27, $2.76B cap
Amcor PLC (AMCR) versus Soleno Therapeutics Inc (SLNO) — a side-by-side from cached financials, not a winner call.
Amcor PLC (AMCR) is a packaging & containers company listed on US.
Soleno Therapeutics Inc (SLNO) is a biotechnology company listed on NASDAQ.
Latest reported AMCR revenue for 2026-06-30 was $23.51B. Net income was $1.11B. Revenue was up 362.5% from 2025-06-30 to 2026-06-30. AMCR currently screens at market cap $22.52B and trailing P/E 17.6.
SLNO does not have a complete income-statement cache yet.
AMCR currently screens at market cap $22.52B and trailing P/E 17.6. SLNO currently screens at market cap $2.76B and trailing P/E 27.5.
Not investment advice. Open the AMCR and SLNO stock pages for the full models.
Not investment advice.